House GOP Advances $95 Billion Reconciliation Plan for War and Elections
House Republicans unveiled a strategic budget resolution to bypass Senate filibusters, seeking $73 billion for the Iran conflict and federal incentives for proof-of-citizenship voting requirements.
Base Activates Azul Upgrade Advancing Layer 2 Decentralization Standards
The Coinbase-incubated Base network has deployed its Azul upgrade, introducing a multiproof system and new client architecture to move the Ethereum Layer 2 toward Stage 2 decentralization.
Inflation Slowdown Sparks Market Rotation as AI Rally Faces Fresh Scrutiny
Cooling U.S. inflation data has triggered a significant shift in global markets, lowering Treasury yields and prompting a pivot from high-flying tech stocks toward broader, cyclical sectors.
AI infra funding surges as model makers race for scale
Recent funding data shows capital pouring into AI infrastructure, while major cloud and enterprise players keep expanding the ecosystem around model deployment, data, and search.
American Innovation Breakthrough as Physicists Create First Room-Temperature Quantum Material
A major discovery in condensed matter physics has overcome the cooling barrier, paving the way for practical quantum computers and secure national communications without expensive cryogenic infrastructure.
Judicial Rulings Redefine Liability Standards for AI and Domestic Labor
Courts in the United States and India are establishing new benchmarks for user accountability in AI misuse and the economic valuation of unpaid domestic work.
Hidden Job Market Cracks Emerge as Long-Term Unemployment Hits Two Million
Despite a headline unemployment rate of 4.2 percent, two million Americans remain jobless for over six months as labor force participation drops to its lowest level since 2021.
Media Consolidation Ethics Clouded by Gifts and DOJ Approval
The $111 billion Paramount-Warner Bros. Discovery merger faces intense scrutiny as ethics scandals at the FCC and DOJ confirmation hearings reveal deep institutional ties to corporate giants.
AI Drug Discovery Funding Surges Amid Regulatory Shifts and Staffing Crises
Massive capital injections into AI-first drug platforms highlight a shift toward high-tech pharmaceutical development as global healthcare systems struggle with labor unrest and access to life-saving treatments.



